Guardian Pharmacy Services, Inc. (GRDN) shareholders
Close on Nov 17, 2026Market cap $3.19BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Thomas J. Salentine, Jr. Joint filing with Bindley Capital Partners I, LLC (26.30%), William E. Bindley (26.30%) and 3 more | 16,705,380 | 26.40% | 13D (active) amendment | Sep 27, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (5.00%) | 3,138,459 | 5.00% | 13G (passive) amendment | Sep 30, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (6.50%) | 2,359,357 | 6.50% | 13G (passive) | Mar 31, 2026 |
| J. Goldman Capital Management, Inc. Joint filing with J. Goldman & Co LP (8.20%), Goldman Jay G (8.20%) | 751,084 | 8.20% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GRDN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 3,241,612 | 5.12% | $135.73M | +882,255 | 0.01% |
| Wellington Management Group Llp | 1,729,032 | 2.73% | $72.39M | −36,087 | 0.01% |
| BlackRock, Inc. | 1,575,989 | 2.49% | $65.99M | −180,385 | 0.00% |
| Vanguard Capital Management LLC | 1,379,750 | 2.18% | $57.77M | +154,207 | 0.00% |
| Woodline Partners LP | 1,306,340 | 2.06% | $54.70M | +22 | 0.17% |
| Valiant Capital Management, L.P. | 1,186,658 | 1.87% | $49.69M | – | 2.01% |
| T. Rowe Price Investment Management, Inc. | 1,116,868 | 1.76% | $46.76M | +88,479 | 0.03% |
| Boston Partners | 983,868 | 1.55% | $40.80M | −33,815 | 0.04% |
| Franklin Resources Inc | 966,206 | 1.53% | $40.46M | +13,254 | 0.01% |
| TimesSquare Capital Management, LLC | 951,637 | 1.50% | $39.85M | −125,837 | 586.04% |
| Loomis Sayles & Co L P | 869,836 | 1.37% | $36.42M | −61,853 | 0.05% |
| Boone Capital Management LLC | 711,939 | 1.12% | $29.81M | +80,746 | 6.97% |
| Geode Capital Management, LLC | 646,695 | 1.02% | $27.08M | +87,660 | 0.00% |
| Jennison Associates LLC | 626,664 | 0.99% | $26.24M | −196,120 | 0.02% |
| State Street Corp | 590,114 | 0.93% | $24.71M | +81,096 | 0.00% |
| Bessemer Group Inc | 548,029 | 0.87% | $22.95M | +469,373 | 0.03% |
| Brown Advisory Inc | 524,013 | 0.83% | $21.94M | −735,161 | 0.03% |
| Dimensional Fund Advisors LP | 516,094 | 0.81% | $21.61M | +307,500 | 0.00% |
| Driehaus Capital Management LLC | 510,161 | 0.81% | $21.36M | −78,960 | 0.12% |
| First Trust Advisors LP | 461,307 | 0.73% | $19.31M | +367,630 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 189 | 30M | 46.6% | 36 / 74 | 53 / 15 | 5M | 4M |
| Q1 2026 | 171 | 28M | 44.7% | 59 / 52 | 42 / 14 | 12M | 2M |
| Q4 2025 | 129 | 20M | 31.5% | 33 / 53 | 32 / 16 | 3M | 3M |
| Q3 2025 | 112 | 20M | 31.1% | 23 / 56 | 23 / 16 | 5M | 4M |
| Q2 2025 | 105 | 18M | 28.7% | 36 / 46 | 14 / 3 | 9M | 1M |
| Q1 2025 | 74 | 10M | 16.3% | 14 / 26 | 22 / 6 | 2M | 1M |
| Q4 2024 | 68 | 10M | 15.1% | 35 / 15 | 15 / 18 | 4M | 3M |
| Q3 2024 | 51 | 8M | 13.3% | 51 / 0 | 0 / 0 | 8M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
216 funds held GRDN in Q2 2026, 27% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of GRDN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,028,313 | 1.62% | $43.06M | 0.00% | Jun 30, 2026 |
| Fidelity Stock Selector Small Cap Fund | 538,325 | 0.85% | $21.28M | 0.29% | Jul 31, 2026 |
| Putnam Core Equity Fund | 508,135 | 0.80% | $20.09M | 0.32% | Jul 31, 2026 |
| Fidelity Small Cap Growth Fund | 476,800 | 0.75% | $18.85M | 0.21% | Jul 31, 2026 |
| iShares Russell 2000 ETF | 472,787 | 0.75% | $19.80M | 0.02% | Jun 30, 2026 |
| Loomis Sayles Small Cap Growth Fund | 470,706 | 0.74% | $19.71M | 0.87% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 341,114 | 0.54% | $14.28M | 0.15% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 319,615 | 0.50% | $13.38M | 0.01% | Jun 30, 2026 |
| Fidelity Series Small Cap Opportunities Fund | 309,044 | 0.49% | $12.22M | 0.26% | Jul 31, 2026 |
| AST Small-Cap Equity Portfolio | 288,517 | 0.46% | $12.08M | 0.57% | Jun 30, 2026 |
| Brown Advisory Small-Cap Fundamental Value Fund | 280,347 | 0.44% | $11.74M | 0.95% | Jun 30, 2026 |
| Templeton Global Smaller Companies Fund | 272,240 | 0.43% | $10.55M | 1.30% | May 31, 2026 |
| Fidelity Small Cap Stock Fund | 248,700 | 0.39% | $9.83M | 0.73% | Jul 31, 2026 |
| Fidelity Small Cap Growth K6 Fund | 241,711 | 0.38% | $9.55M | 0.21% | Jul 31, 2026 |
| Boston Partners Small Cap Value Fund II | 211,260 | 0.33% | $8.18M | 1.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David K. Morris | See Remarks, Director | 896,341 | 1.42% | Sep 28, 2026 |
| Fred Burke | See Remarks, Director | 3,438,064 | 5.43% | Sep 28, 2026 |
| Douglas Towns | See Remarks | 113,006 | 0.18% | Sep 28, 2026 |
| Richard Eakins | Senior Vice President, Sales | 134,930 | 0.21% | Sep 28, 2026 |
| Jeffrey Tuch | See Remarks | 231,847 | 0.37% | Sep 28, 2026 |
| Robert Weir | See Remarks | 103,333 | 0.16% | Sep 28, 2026 |
| David Norman Martin | See Remarks | 140,905 | 0.22% | Sep 28, 2026 |
| Chris Crisafulli | See Remarks | 53,057 | 0.08% | Sep 28, 2026 |
| William Franklin Mudd | See Remarks | 136,747 | 0.22% | Sep 28, 2026 |
| Thomas J. Salentine Jr | Director, 10% owner | 16,705,380 | 26.37% | Sep 28, 2026 |
| John Ackerman | Director | 5,151,043 | 8.13% | Sep 28, 2026 |
| William E. Bindley | Director, 10% owner | 16,669,666 | 26.32% | Sep 28, 2026 |
| Mary Sue Patchett | Director | 15,071 | 0.02% | May 7, 2026 |
| Steven D. Cosler | Director | 29,012 | 0.05% | May 7, 2026 |
| Randall J. Lewis | Director | 15,071 | 0.02% | May 7, 2026 |
| Cardinal Equity Fund, L.P. | – | 1,287,237 | 2.03% | Sep 28, 2026 |
| Pharmacy Investors, LLC | – | 3,863,806 | 6.10% | Sep 28, 2026 |
| Bindley Capital Partners I, LLC | 10% owner | 16,669,666 | 26.32% | Sep 28, 2026 |
| Kendall Forbes | – | 1,651,059 | 2.61% | Sep 28, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William E. Bindley Director, 10% owner | Sep 27, 2026 | Option exercise | +6,100,175 | – | – | 16,669,666 |
| Fred Burke See Remarks, Director | Sep 27, 2026 | Option exercise | +1,298,825 | – | – | 3,438,064 |
| David K. Morris See Remarks, Director | Sep 27, 2026 | Option exercise | +641,870 | – | – | 896,341 |
| Thomas J. Salentine Jr Director, 10% owner | Sep 27, 2026 | Option exercise | +6,100,175 | – | – | 16,669,666 |
| William Franklin Mudd See Remarks | Sep 27, 2026 | Option exercise | +38,282 | – | – | 136,747 |
| Bindley Capital Partners I, LLC 10% owner | Sep 27, 2026 | Option exercise | +6,100,175 | – | – | 16,669,666 |
| Chris Crisafulli See Remarks | Sep 27, 2026 | Option exercise | +18,931 | – | – | 53,057 |
| David Norman Martin See Remarks | Sep 27, 2026 | Option exercise | +39,865 | – | – | 140,905 |
| Robert Weir See Remarks | Sep 27, 2026 | Option exercise | +23,450 | – | – | 103,333 |
| Pharmacy Investors, LLC – | Sep 27, 2026 | Option exercise | +1,413,939 | – | – | 3,863,806 |
| John Ackerman Director | Sep 27, 2026 | Option exercise | +1,413,939 | – | – | 3,863,806 |
| John Ackerman Director | Sep 27, 2026 | Option exercise | +471,057 | – | – | 1,287,237 |
| Douglas Towns See Remarks | Sep 27, 2026 | Option exercise | +23,450 | – | – | 113,006 |
| Cardinal Equity Fund, L.P. – | Sep 27, 2026 | Option exercise | +471,057 | – | – | 1,287,237 |
| Jeffrey Tuch See Remarks | Sep 27, 2026 | Option exercise | +55,578 | – | – | 231,847 |
| Kendall Forbes – | Sep 27, 2026 | Option exercise | +608,570 | – | – | 1,651,059 |
| Richard Eakins Senior Vice President, Sales | Sep 27, 2026 | Option exercise | +36,052 | – | – | 134,930 |
| Randall J. Lewis Director | May 5, 2026 | Award | +4,028 | – | – | 15,071 |
| Mary Sue Patchett Director | May 5, 2026 | Award | +4,028 | – | – | 15,071 |
| Steven D. Cosler Director | May 5, 2026 | Award | +4,028 | – | – | 29,012 |
| Fred Burke See Remarks, Director | Mar 28, 2026 | Option exercise | +1,298,826 | – | – | 2,139,239 |
| Pharmacy Investors, LLC – | Mar 28, 2026 | Option exercise | +1,413,939 | – | – | 2,449,867 |
| Cardinal Equity Fund, L.P. – | Mar 28, 2026 | Option exercise | +471,057 | – | – | 816,180 |
| Kendall Forbes See Remarks | Mar 28, 2026 | Option exercise | +608,570 | – | – | 1,061,826 |
| William E. Bindley Director, 10% owner | Mar 28, 2026 | Option exercise | +6,100,175 | – | – | 10,569,491 |
| Bindley Capital Partners I, LLC 10% owner | Mar 28, 2026 | Option exercise | +6,100,175 | – | – | 10,569,491 |
| David K. Morris See Remarks, Director | Mar 28, 2026 | Option exercise | +641,869 | – | – | 896,341 |
| Thomas J. Salentine Jr Director, 10% owner | Mar 28, 2026 | Option exercise | +6,100,175 | – | – | 10,569,491 |
| John Ackerman Director | Mar 28, 2026 | Option exercise | +471,057 | – | – | 816,180 |
| John Ackerman Director | Mar 28, 2026 | Option exercise | +1,413,939 | – | – | 2,449,867 |
| Cardinal Equity Fund, L.P. – | Mar 20, 2026 | Sale | −275,728 | $29.68 | $8.18M | 345,123 |
| Pharmacy Investors, LLC – | Mar 20, 2026 | Sale | −827,636 | $29.68 | $24.56M | 1,035,928 |
| Fred Burke See Remarks, Director | Mar 20, 2026 | Sale | −671,432 | $29.68 | $19.93M | 840,413 |
| David K. Morris See Remarks, Director | Mar 20, 2026 | Sale | −187,855 | $29.68 | $5.58M | 254,472 |
| John Ackerman Director | Mar 20, 2026 | Sale | −827,636 | $29.68 | $24.56M | 1,035,928 |
| John Ackerman Director | Mar 20, 2026 | Sale | −275,728 | $29.68 | $8.18M | 345,123 |
| Kendall Forbes See Remarks | Mar 20, 2026 | Sale | −346,672 | $29.68 | $10.29M | 453,256 |
| Thomas J. Salentine Jr Director, 10% owner | Mar 20, 2026 | Sale | −3,570,677 | $29.68 | $105.98M | 4,469,316 |
| Bindley Capital Partners I, LLC 10% owner | Mar 20, 2026 | Sale | −3,570,677 | $29.68 | $105.98M | 4,469,316 |
| William E. Bindley Director, 10% owner | Mar 20, 2026 | Sale | −3,570,677 | $29.68 | $105.98M | 4,469,316 |
| Kendall Forbes See Remarks | Mar 1, 2026 | Award | +8,952 | – | – | 799,928 |
| David K. Morris See Remarks, Director | Mar 1, 2026 | Award | +8,952 | – | – | 442,327 |
| Fred Burke See Remarks, Director | Dec 4, 2025 | Gift | −200,000 | – | – | 1,511,845 |
| Kendall Forbes See Remarks | Dec 4, 2025 | Gift | −21,500 | – | – | 790,976 |
| Steven D. Cosler Director | Dec 3, 2025 | Buy | +3,370 | $29.61 | $99.79K | 24,984 |
| Bindley Capital Partners I, LLC 10% owner | Sep 27, 2025 | Option exercise | +6,100,176 | – | – | 8,039,993 |
| Cardinal Equity Fund, L.P. – | Sep 27, 2025 | Option exercise | +471,057 | – | – | 620,851 |
| Pharmacy Investors, LLC – | Sep 27, 2025 | Option exercise | +1,413,940 | – | – | 1,863,564 |
| John Ackerman Director | Sep 27, 2025 | Option exercise | +471,057 | – | – | 620,851 |
| John Ackerman Director | Sep 27, 2025 | Option exercise | +1,413,940 | – | – | 1,863,564 |
| Kendall Forbes See Remarks | Sep 27, 2025 | Option exercise | +608,570 | – | – | 812,476 |
| Fred Burke See Remarks, Director | Sep 27, 2025 | Option exercise | +1,298,826 | – | – | 1,711,845 |
| Thomas J. Salentine Jr Director, 10% owner | Sep 27, 2025 | Option exercise | +6,100,176 | – | – | 8,039,993 |
| William E. Bindley Director, 10% owner | Sep 27, 2025 | Option exercise | +6,100,176 | – | – | 8,039,993 |
| David K. Morris See Remarks, Director | Sep 27, 2025 | Option exercise | +641,869 | – | – | 856,364 |
| Cardinal Equity Fund, L.P. – | May 28, 2025 | Sale | −50,305 | $20.16 | $1.01M | 149,794 |
| Pharmacy Investors, LLC – | May 28, 2025 | Sale | −150,998 | $20.16 | $3.04M | 449,624 |
| Fred Burke See Remarks, Director | May 28, 2025 | Sale | −138,705 | $20.16 | $2.80M | 413,019 |
| David K. Morris See Remarks, Director | May 28, 2025 | Sale | −68,547 | $20.16 | $1.38M | 214,495 |
| Thomas J. Salentine Jr Director, 10% owner | May 28, 2025 | Sale | −651,454 | $20.16 | $13.13M | 1,939,817 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Guardian Pharmacy Services's stock actually held short. Settlement fails (shares not delivered on time) peaked at 700 shares on Sep 21, 2026 over the last 90 days.
See a number that looks wrong?